Bausch + Lomb Corp.

About Bausch + Lomb Corp.

Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.

Founded

1853

CEO

Mr. Brenton L. Saunders

Employees

13,000

Headquarters

Vaughan, Ontario, Canada

Fiscal year end

12-31

Website

bausch.com

Company profile

Exchange

US

Symbol

BLCO

Market-cap rank

#1909

Listing date

2022-05-06

Market cap

6.19B

Float cap

789.79M

Shares out

357.17M

Float shares

45.55M

Sectors & themes

Browse all sectors & themes